These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27287300)

  • 21. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.
    Likanonsakul S; Suntisuklappon B; Nitiyanontakij R; Prasithsirikul W; Nakayama EE; Shioda T; Sangsajja C
    PLoS One; 2016; 11(1):e0147724. PubMed ID: 26807589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued.
    Nishijima T; Mutoh Y; Kawasaki Y; Tomonari K; Kikuchi Y; Gatanaga H; Oka S;
    AIDS; 2018 Jan; 32(2):179-188. PubMed ID: 29028660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men.
    Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella F; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak M
    J Acquir Immune Defic Syndr; 2016 Oct; 73(2):177-81. PubMed ID: 27088295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
    Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
    AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial.
    Decloedt EH; Lesosky M; Maartens G; Joska JA
    AIDS Res Ther; 2017 Feb; 14(1):6. PubMed ID: 28160772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Prolonged Administration of Tenofovir Disoproxil Fumarate-Containing Antiviral Regimen on Renal Function in Low-Risk of Kidney Injury HIV Patients.
    Yuan Y; He S; Liu H; He Y; Zhou R; Yao Y; Yin K; Lyu C
    J Clin Pharmacol; 2024 May; 64(5):626-633. PubMed ID: 38323669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
    Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
    Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
    AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Tenofovir Use With Risk of Incident Heart Failure in HIV-Infected Patients.
    Chen R; Scherzer R; Hsue PY; Jotwani V; Estrella MM; Horberg MA; Grunfeld C; Shlipak MG
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
    Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
    J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
    Kinai E; Hanabusa H
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy.
    Dauchy FA; Lawson-Ayayi S; de La Faille R; Bonnet F; Rigothier C; Mehsen N; Miremont-Salamé G; Cazanave C; Greib C; Dabis F; Dupon M
    Kidney Int; 2011 Aug; 80(3):302-9. PubMed ID: 21544066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific.
    Tanuma J; Jiamsakul A; Makane A; Avihingsanon A; Ng OT; Kiertiburanakul S; Chaiwarith R; Kumarasamy N; Nguyen KV; Pham TT; Lee MP; Ditangco R; Merati TP; Choi JY; Wong WW; Kamarulzaman A; Yunihastuti E; Sim BL; Ratanasuwan W; Kantipong P; Zhang F; Mustafa M; Saphonn V; Pujari S; Sohn AH;
    PLoS One; 2016; 11(8):e0161562. PubMed ID: 27560968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
    Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?
    Marcelin JR; Berg ML; Tan EM; Amer H; Cummins NW; Rizza SA
    PLoS One; 2016; 11(2):e0149562. PubMed ID: 26872144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary α 1-microglobulin and β 2-microglobulin as markers of early kidney injury in HIV-positive male patients on tenofovir-based antiretroviral therapy.
    Yu XL; Sun W; Liu L; Hong K; Song H
    PLoS One; 2024; 19(6):e0303442. PubMed ID: 38885284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.